Publication:
The use of rivaroxaban in deep venous thrombosis associated with vena cava inferior agenesis

No Thumbnail Available
Date
2019-10-01T00:00:00Z
Authors
Arikan, Ali Ahmet
Emre, Selcuk
Avni, Bayraktar Fatih
Journal Title
Journal ISSN
Volume Title
Publisher
Research Projects
Organizational Units
Journal Issue

Metrics

Search on Google Scholar

Abstract
Inferior vena cava agenesis is a rare anomaly which may result in deep vein thrombosis. There is no clear scientific evidence for the most effective therapeutic management, optimal duration, or the choice of anticoagulant therapy. Herein, we report an 18-year-old male case with deep vein thrombosis associated with inferior vena cava agenesis who was on rivaroxaban as a lifelong anticoagulation treatment for symptoms of venous stasis and the presence of heterozygotic thrombophilic mutations.
Description
Keywords
Citation
Arikan A. A. , Emre S., Avni B. F. , -The use of rivaroxaban in deep venous thrombosis associated with vena cava inferior agenesis-, TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, cilt.27, ss.583-585, 2019
Collections
Page Views

2

File Downloads

0

Sustainable Development Goals